AUROPHARMA taking support on monthly trend line and 20 dma
Updated
its attempt to cross target 1 getting rejected.
with no negative news
if crosses target 1 target 2 and target 3
possible.
with no negative news
if crosses target 1 target 2 and target 3
possible.
Note
usa decision to reduce drug prices may have negative impact.little bad news for pharma companies.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.